TrialX
Image

Rheumatology Patient Registry and Biorepository

Rheumatology Patient Registry and Biorepository

Recruiting
18-99 years
All
Phase N/A

Overview

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Description

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease. Healthy volunteers are also invited to participate in this study.

Eligibility

Inclusion Criteria for Rheumatology Patients:

  • Patients 18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis.

Exclusion Criteria for Rheumatology Patients:

  • Unable to provide informed consent
  • No patients will be excluded based on gender or ethnicity or pregnancy status.
  • Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver.
  • Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy.

Inclusion Criteria for Healthy Volunteers:

  • Age 18 years old
  • No chronic skin conditions
  • No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis)
  • Normal BMI

Exclusion Criteria for Healthy Volunteers:

  • Unable to provide informed consent.
  • Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman.
  • Allergies to lidocaine or epinephrine (skin biopsies).
  • A history of impaired wound healing (skin biopsies).

Study details
    Dermatomyositis
    Rheumatism
    Ankylosing spondylitis
    Ankylosing spondylitis
    Psoriasis
    Antiphospholipid Syndrome
    Antiphospholipid Syndrome
    Behcet's Syndrome
    Adult Onset Still's Disease
    CONNECTIVE TISSUE DISEASE
    dermatomyositis (connective tissue disease)
    Sicca Syndrome
    Reiter's syndrome
    Reiter's syndrome
    PSORIATIC ARTHRITIS
    PSORIATIC ARTHRITIS
    Lyme Disease
    Lyme Disease
    Giant Cell Arteritis
    Rheumatoid Arthritis
    Rheumatoid Arthritis
    Scleroderma
    Systemic sclerosis
    Scleroderma
    Anterior uveitis
    Anterior uveitis
    Polymyalgia Rheumatica
    Myositis
    Myositis
    Dermatosis
    SYSTEMIC LUPUS ERYTHEMATOSUS
    SYSTEMIC LUPUS ERYTHEMATOSUS
    Lyme Disease Vaccine
    Musculoskeletal Disease
    Lymphoproliferative Disorder
    Mixed Connective Tissue Disease
    Sarcoidosis
    Sarcoidosis
    Arthritis
    Polymyositis
    dermatomyositis (connective tissue disease)

NCT04402086

Yale University

5 August 2020

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.